SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-07-015319
Filing Date
2007-03-29
Accepted
2007-03-29 17:12:53
Documents
9
Period of Report
2007-03-29

Document Format Files

Seq Description Document Type Size
1 v069816_6k.htm 6-K 18701
2 v069816_ex99-1.htm EX-99.1 1195
3 GRAPHIC v069816_ex99-1x1x1.jpg GRAPHIC 53623
4 GRAPHIC v069816_ex99-1x2x1.jpg GRAPHIC 55723
5 GRAPHIC v069816_ex99-1x3x1.jpg GRAPHIC 38883
6 GRAPHIC v069816_ex99-1x4x1.jpg GRAPHIC 77256
7 GRAPHIC v069816_ex99-1x5x1.jpg GRAPHIC 119211
8 GRAPHIC v069816_ex99-1x6x1.jpg GRAPHIC 120527
9 GRAPHIC v069816_ex99-1x7x1.jpg GRAPHIC 75606
  Complete submission text file 0001144204-07-015319.txt   767472
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 07728461
SIC: 2834 Pharmaceutical Preparations